Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Doxorubicin Adverse Reaction”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Large-scale testing (Phase 3)Study completedNCT00245050
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganEndometrial Cancer+3 more
Case Comprehensive Cancer Center 34
Not applicableStudy completedNCT00577798
What this trial is testing

Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

Who this might be right for
Cardiac ToxicityChemotherapeutic Agent ToxicityLymphoma
University of Nebraska 10
Not applicableUnknownNCT04461223
What this trial is testing

Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR

Who this might be right for
CardiotoxicityOsteosarcomaMyocardial Injury+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 55
Testing effectiveness (Phase 2)Study completedNCT06155331
What this trial is testing

Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer Stage 2 and 3
Tanta University 44
Not applicableStudy completedNCT00875238
What this trial is testing

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Who this might be right for
Breast CancerCardiac ToxicityCardiovascular Complications
Vanderbilt University 133
Large-scale testing (Phase 3)Study completedNCT00854568
What this trial is testing

Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Who this might be right for
Lymphoma
Fudan University 398
Not applicableStudy completedNCT02796365
What this trial is testing

Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy

Who this might be right for
Doxorubicin Induced CardiomyopathyBreast CancerGastric Cancer+1 more
Henry Ford Health System 29
Testing effectiveness (Phase 2)Ended earlyNCT00377780
What this trial is testing

Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
Laurence J.C. van Warmerdam 60
Not applicableStudy completedNCT01751893
What this trial is testing

Testing the Effectiveness of Henna on Managing PPE

Who this might be right for
Palmar-plantar Erythrodysesthesia (PPE)
Cyprus University of Technology 56
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Not applicableUnknownNCT01246856
What this trial is testing

MIBG Scintigraphy and Strain Echocardiography in the Detection of Subclinical Cardiovascular Effects One Year After (Neo)Adjuvant Breast Cancer Treatment With Docetaxel, Doxorubicin and Cyclophosphamide (TAC): a Pilot Study

Who this might be right for
Breast Cancer
Radboud University Medical Center 150
Testing effectiveness (Phase 2)Ended earlyNCT01120171
What this trial is testing

Myocet Plus Endoxan for Older Patients With Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 64
Large-scale testing (Phase 3)Ended earlyNCT00016276
What this trial is testing

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Who this might be right for
Cardiac ToxicityInflammatory Breast CancerStage IIIA Breast Cancer+2 more
National Cancer Institute (NCI) 396
Not applicableStudy completedNCT04568161
What this trial is testing

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Who this might be right for
CardiotoxicityCardiovascular DiseaseNeurovascular Disorder+2 more
University of Sao Paulo General Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01095926
What this trial is testing

Pharmacokinetic Study of Doxorubicin in Children With Cancer

Who this might be right for
Wilms TumorNeuroblastomaSoft Tissue Sarcoma+1 more
University Hospital Muenster 101
Large-scale testing (Phase 3)Study completedNCT00992706
What this trial is testing

F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer

Who this might be right for
Breast CancerPalmar-plantar Erythrodysesthesia
Swiss Cancer Institute 91
Not applicableStudy completedNCT05755646
What this trial is testing

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial

Who this might be right for
Hand-Foot SyndromeBreast Cancer
University Hospital Tuebingen 36
Testing effectiveness (Phase 2)Study completedNCT01205503
What this trial is testing

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Who this might be right for
Breast CancerNon-Hodgkin's Lymphoma
Mara Chambers 32
Testing effectiveness (Phase 2)Study completedNCT00248248
What this trial is testing

DOXIL for Consolidation Therapy in Ovarian Cancer.

Who this might be right for
Ovarian Neoplasm
Southeastern Gynecologic Oncology 45
Load More Results